Xellia Pharmaceuticals
Anti-infective drug development
- B2B
About Xellia Pharmaceuticals
Global leader in providing critical care therapies and anti-infective treatments, from APIs to FDFs, with a focus on reliable supply, quality, sustainability, and patient care
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- copenhagen, capital region of denmark, Denmark
- Founded
- 1903
- Revenue
- $63.7M – $503MTamtam estimate
- Website
- xellia.com
Xellia Pharmaceuticals at a glance
Xellia Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in copenhagen, capital region of denmark, Denmark.
Xellia Pharmaceuticals was founded in 1903.
Xellia Pharmaceuticals has 251–1,000 employees.
Xellia Pharmaceuticals's revenue is $63.7M – $503M (Tamtam estimate).
Selling to companies like Xellia Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies